Results 111 to 120 of about 10,942 (165)

Global Epidemiology of Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review. [PDF]

J Epidemiol Glob Health
Zorina O, Beiki O, Holt M, Buisker J, Ferber P, Fermont JM, Kelly RJ.   +6 more
europepmc   +1 more source

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Drug Des Devel Ther
Chen C, Zhong J, Xiong D.
europepmc   +1 more source

Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety. [PDF]

Hemasphere
Griffin M, Fattizzo B, Lee JW, Kelly RJ, Trikha R, Ueda Y, Nishimura JI, Patriquin CJ, Röth A, Muus P, Panse J, Álvarez MG, Pike A, Munir T, Gandhi S, Kulasekararaj A.   +15 more
europepmc   +1 more source

Interleukin-6 in hemolytic anemias: from inflammatory pathways to therapeutic targeting. [PDF]

Front Immunol
Zhao M, Yu X.
europepmc   +1 more source

Thrombotic Events in Patients With Paroxysmal Nocturnal Haemoglobinuria Using Eculizumab: A Post-Marketing Surveillance Sub-Analysis. [PDF]

EJHaem
Ikezoe T, Kawaguchi T, Hayashi H, Shimono A, Nishimura JI.   +4 more
europepmc   +1 more source

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy. [PDF]

Hemasphere
Kulasekararaj A, de Fontbrune FS, Gaya A, Weitz I, Kuter DJ, Patel BJ, Araten DJ, Singh A, Jang JH, Kelly RJ, Di Bona E, Loschi M, Pullarkat V, Schubert J, Notaro R, Yenerel MN, Beckman J, Blin N, Murakhovskaya I, Panse J, Roman E, Röth A, Schrezenmeier H, Tantravahi S, de Latour RP, Mahajan N, Monaco L, Ding T, Lawniczek T, Ferber P, Dahlke M, Risitano AM.   +31 more
europepmc   +1 more source

Haploidentical allogeneic haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria: a retrospective analysis. [PDF]

Ann Hematol
Bi JY, Zhang YY, Fu HX, He Y, Han TT, Chen Y, Wang ZD, Kong J, Wang JZ, Mo XD, Sun YQ, Cheng YF, Chen YH, Wang Y, Zhang XH, Huang XJ, Xu ZL, Xu LP.   +17 more
europepmc   +1 more source

Activated Platelets Express GPI-Anchored Fibrocystin-L (PKHD1L1), from Granules, Absent or Deficient in Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Int J Mol Sci
Polgar J, Clemetson JM, Magnenat E, Wells TN, Röss H, Rochat S, Alberio LA, Clemetson KJ.   +7 more
europepmc   +1 more source

Analysis of the Recovery of Immune Status in the Patients With Paroxysmal Nocturnal Hemoglobinuria After Treatment With C5 Complement Inhibitor. [PDF]

J Clin Lab Anal
Liu H, Che M, Li L, Wang H, Wang C, Wu J, Chen Y, Liu Z, Li L, Fu R.   +9 more
europepmc   +1 more source

Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Health Sci Rep
Dingli D, Broderick L, Rizio AA, Rucker S, LaGasse K, Carty MK, Burton E, Gordon S, Yen GP, Paulose J, Geevarghese A, Lee S.   +11 more
europepmc   +1 more source